Editor's Note Tubal sterilization, often considered a permanent form of contraception, has a failure rate of 3% to 5%, leading to unplanned pregnancies in some cases, UC San Francisco reported August 27. Publishing in NEJM Evidence, university researchers report that contraceptive arm implants or intrauterine devices (IUDs) may be more reliable…
Editor's Note Nearly 20 years of data on the first 50 face transplants in the world indicate that survival rates exceed those of several solid organ transplants, according to a global study published September 18 in Jama Surgery. Conducted between 2005 and 2021, the study involved 18 transplant centers, assessed…
Editor's Note In partnership with the World Health Organization (WHO), The Joint Commission and The Joint Commission and Joint Commission International (JCI) invite organizations, health professionals, patients, and their advocates to recognize World Patient Safety Day Tuesday, September 17. This year’s theme is “improving diagnosis for patient safety.” This theme…
Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9. The study, which analyzed 31,725 adults waitlisted for…
Editor's Note Research shows black women are 25% more likely to undergo cesarean sections (C-sections) than white women, even when presenting similar medical histories, The New York Times reported September 10. The article focuses on a study analyzing nearly one million births across 68 New Jersey hospitals. Conducted between 2008…
Editor's Note The Centers for Medicare & Medicaid Services (CMS) is expanding its social determinants of health (SDoH) initiatives to include outpatient settings, starting with voluntary reporting in 2025 and moving to mandatory reporting in 2026, MedLearn Publishing August 26 reports. This expansion aims to address gaps in care by…
Human trafficking (HT) is a global public health crisis and one of the fastest growing criminal enterprises that grosses hundreds of billions of dollars annually, all of which are tax-free profits made off the sale of human cargo. And yet, research shows the problem is poorly understood or recognized among…
Perioperative leaders face mounting pressures to optimize resources, reduce costs, and improve patient outcomes. However, one challenge stands out among the rest: OR staffing shortages. According to a November/December survey conducted by LeanTaaS in collaboration with OR Manager, staff recruitment and retention is a top priority for OR leaders this…
Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events. These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…
Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…